Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy-Reference-Cited by-同舟云学术

Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy

Published:1999-07 Issue:11 Volume:13 Page:F71-F77
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Piketty Christophe,Race Esther,Castiel Philippe,Belec Laurent,Peytavin Gilles,Si-Mohamed Ali,Gonzalez-Canali Gustavo,Weiss Laurence,Clavel François,Kazatchkine Michel D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference21 articles.

1. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

2. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

3. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

4. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

5. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review;Antiviral Therapy;2023-05-22

2. Effect of PEGylation on drug uptake, biodistribution, and tissue toxicity of efavirenz–ritonavir loaded PAMAM G4 dendrimers;Pharmaceutical Development and Technology;2023-02-05

3. Improvement in Bioavailability and Pharmacokinetic Characteristics of Efavirenz with Booster Dose of Ritonavir in PEGylated PAMAM G4 Dendrimers;AAPS PharmSciTech;2022-06-25

4. Role of nanocarriers for the effective delivery of anti-HIV drugs;Photophysics and Nanophysics in Therapeutics;2022

5. Pharmacodynamics of Antiretroviral Agents;Methods in Pharmacology and Toxicology;2016